Answers are grounded in this paper and cite their sources.
Retrospective study investigates nemolizumab's effects on inflammatory indices in prurigo nodularis, suggesting possible benefits.
Yoshihito Mima and Ken Iozumi have received lecture fees from Maruho Co. Ltd., which markets nemolizumab.
No takes yet. Share an insight, caveat, or question.
Mima et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: